Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131469) titled 'Study on the Application of Raman Spectroscopy Technology in the Rapid Pathological Diagnosis of Gliomas' on Sept. 2.
Study Type: Observational study
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Beijing Tiantan Hospital, Capital Medical University
Condition:
Glioma
Intervention:
Glioma:None
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2025-03-23
Target Sample Size: Glioma:155;Non-Glioma:155;
Countries of Recruitment:
CHINA
To know more, visit https://www.chictr.org.cn/showproj.html?proj=300048
Disclaimer: Curated by HT Syndication....